Article
Polymorphisms in CYP3A5*3 and MDR1, and haplotype modulate response to plasma levels of tacrolimus in Chinese renal transplant patients.
Annals of transplantation - 1 Jan 2000
Wu Ping, Ni Xuefeng, Wang Mingli, Xu Xianlin, Luo Guanghua, Jiang Yan
Abstract excerpt
BACKGROUND: The purpose of this study was to investigate the effects of polymorphisms in CYP3A5*3, CYP3AP1, and MDR1, and of haplotype, on plasma levels of tacrolimus in Chinese patients after renal transplantation, and to assess the relationship between polymorphisms and the variability of concentration/dose of tacrolimus for optimization and individualization regimens. MATERIAL/METHODS: The MALDI-TOF method was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
